Tenoxicam

  • TRADE NAMES: Alganex; Dolmen; Liman; Mobiflex (Roche); Rexaglan; Tilcitin; Tilcotil
  • INDICATIONS: Osteoarthritis, rheumatoid arthritis, ankylosing spondylitits and hyperuricemia
  • CLASS: Non-steroidal anti-inflammatory (NSAID)
  • HALF-LIFE: 72 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Cyclosporine, Lithium, Methotrexate, Mifepristone, NSAIDs, Quinolones, Salicylates

NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Our database has 12 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
RENAL.
OTHER.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top